🔥🐔 BizChicken 🐔🔥

Learn About the Corporations Around You

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Context Therapeutics Inc.

Context Therapeutics Inc. logo
Market Cap: Low
Employees: Lowest

onapristone extended release (ONA-XR)

Context Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing cancer treatments for women in the United States. Its main product, ONA-XR, is aimed at resistant female hormone-dependent cancers.

Tags: CLDN6, T-cell-mediated therapy, biopharmaceutical, cancer treatment, monoclonal antibody, oncology, progesterone receptor, women's health

Website

About | Contact | Careers | About | About

Symbol: CNTX

Recent Price: $1.06

Industry: Biotechnology

CEO: Mr. Martin A. Lehr

Sector: Healthcare

Employees: 5

Address: 2001 Market Street, Philadelphia, PA 19103

Phone: 267 225 7416

Last updated: 2024-12-31